A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study of DU-176b in Patients With NVAF Aged 80 Years or Older Who Are Ineligible for Available Oral Anticoagulation Therapy
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study of DU-176b in Patients With NVAF Aged 80 Years or Older Who Are Ineligible for Available Oral Anticoagulation Therapy
The purpose of this study is to evaluate the efficacy and safety of edoxaban in patients with non-valvular NVAF aged 80 years or older who are ineligible for available oral anticoagulation therapy.
Inclusion Criteria:
Exclusion Criteria:
Adachi-ku, 123-0864, Japan
Higashiyamato, 207-0014, Japan
Hiroshima, 730-8518, Japan
Kōriyama, 963-8052, Japan
Meguro-ku, 152-8902, Japan
Shinagawa-Ku, 141-0001, Japan
Shinagawa-Ku, 142-8666, Japan
Shinjuku-Ku, 162-8655, Japan
Shiwa-gun, 020-8505, Japan
Toshima-ku, 170-0001, Japan